We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Invasive Breast Cancer Death Rates Are Falling

By HospiMedica International staff writers
Posted on 03 Aug 2015
Print article
A new analysis has found that since 1988, breast cancer-specific mortality has fallen by nearly one-third.

Researchers at the US National Cancer Institute (NCI; Rockville, MD, USA) and Dongguk University (Seoul, Republic of Korea) conducted a study to estimate hazard ratios for breast cancer specific death from time of invasive breast cancer diagnosis using data from the NCI surveillance, epidemiology, and end result registries database from 1973–2010. The study included 543,171 women with first primary invasive breast cancer. They calculated the proportion of improvements in stage- and age-specific breast cancer survival in the United States—as explained by tumor size or estrogen receptor (ER) status—both with and without stratification.

The results showed that hazards from breast cancer specific death declined from 1973 to 2010, not only in the first five years after diagnosis, but also thereafter. Stratification by tumor size explained less than 17% of the improvements, except for women aged 70 years or older with local (49%) or regional (38%) disease. Additional adjustment for ER status (positive, negative, or unknown) from 1990-2010 did not explain much more of the improvement, except for women aged 70 years or older within five years after diagnosis. The study was published on July 20, 2015, in the Journal of Clinical Oncology.

“These results indicate that factors other than nonsurgical size or ER status accounted for most of the stage-specific survival improvements in women younger than age 70 years,” said corresponding author Mitchell Gail, MD, PhD. “For women 70 years of age and older, changes in nonsurgical size explained much of the improvement from 1973 to 1979 and 2005 to 2010 in the first five years. After five years, neither nonsurgical size alone nor nonsurgical size and ER status explained much improvement in women older than 70 years.”

Studies reveal that the proportion of women who underwent screening mammography increased from 29% in 1987 to approximately 70% from 2000 onward. Other studies indicate that 70% of women age 70 or older with invasive breast cancer received adjuvant hormonal therapy and/or chemotherapy in 2000; 78% of patients aged 50–69 years received such treatment; and for patients younger than 50 years of age, the percentage jumped to 88%.

ER status helps guide treatment for breast cancer. Breast cancers that have a large number of ER+ tumors can be treated with hormone therapies like tamoxifen and aromatase inhibitors, and tumors tend to be linked to better survival than ER- tumors. Overall, five-year survival is about 10% better for women with ER+ breast cancer than for those with ER- tumors. However, after five years, this survival difference begins to decrease and over time may even disappear.

Related Links:
US National Cancer Institute
Dongguk University


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Hydrogen Peroxide Sterilizer
HMA-30

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.